Category: WeedPress Policy Series
-

The Limits of § 822(d): What It Does — and Does Not — Authorize
The Limits of § 822(d): What It Does — and Does Not — Authorize By Jason Karimi | WeedPress Policy Series #5 February 13, 2026 The prior essay argued that the Controlled Substances Act (CSA) is not a blunt prohibition instrument, but a regulatory architecture containing delegated exception authority. That structural claim warrants clarification. This…
-

The Controlled Substances Act Is Not a Blunt Instrument — It Is an Architecture of Exceptions
The Controlled Substances Act Is Not a Blunt Instrument — It Is an Architecture of Exceptions By Jason Karimi | WeedPress Policy Series #4| February 13, 2026 A recent Harvard Law Review–discussed argument (as reviewed in Drug Scheduling Is Institutional Design — And That Changes Everything) suggests the Controlled Substances Act (CSA) is structurally imperfect…
-

Structural Contradictions and Prospective Litigation Risk in Post-Rescheduling Cannabis Policy
WEEDPRESS POLICY SERIES™ No. 3 Title: Structural Contradictions and Prospective Litigation Risk in Post-Rescheduling Cannabis PolicyAuthor: Jason KarimiPublication: WeedpressDate: February 6, 2026 Document Type: Legal Memorandum | Executive Brief | Policy Analysis | Version 1.0 Weedpress.org/memo-structural-contradictions-and-litigation-exposure-in-post-rescheduling-cannabis-policy _____ About Weedpress Policy Series The Weedpress Policy Series publishes in-depth, citation-supported analysis of federal cannabis law, regulatory policy, and…
-

The Path to a Religious Cannabis Exemption: Why Medical Cannabis Systems Change the RFRA Equation
WEEDPRESS POLICY SERIES™ Federal Cannabis Law, Policy, and Oversight WeedPress Policy Series No. 2 Title: The Path to a Religious Cannabis Exemption: How Medical Cannabis Systems Change the RFRA Equation Author: Jason Karimi Publication: WeedPress Date: January 27, 2026 Document Type: Policy Analysis | Legal Memorandum | Investigative Report | RFRA & Religious Liberty Brief…
-

Legal Memorandum: Common Misconceptions in Cannabis Activism Regarding Federal Drug Law
WEEDPRESS POLICY SERIES™ Federal Cannabis Law, Policy, and Oversight Weedpress Policy Series No. 1Title: Legal Memorandum: Common Misconceptions in Cannabis Activism Regarding Federal Drug LawAuthor: Jason KarimiPublication: WeedpressDate: January 25 2025 Document Type: Legal Memorandum | Executive Brief | Policy Analysis | Investigative Report Weedpress.org/legal-memorandum-common-misconceptions-in-cannabis-activism-regarding-federal-drug-law ⸻ About Weedpress Policy Series The Weedpress Policy Series publishes…